Taiwan FDA registration 9428a4d34bb5b071649156d13349fc60
2nd Generation Total Cholesterol Test System (Unsterilized)
TW: 百捷優第二代總膽固醇檢驗系統 (未滅菌)
Taiwan·Risk Class 1·Qinli Biotechnology Co., Ltd. New North Plant·Registered Aug 24, 2022 – Aug 24, 2027ActiveRegistration details
- Analysis ID
- 9428a4d34bb5b071649156d13349fc60
Company information
- Manufacturer
- Qinli Biotechnology Co., Ltd. New North Plant
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- GENERAL LIFE BIOTECHNOLOGY CO., LTD.
Product details
- Intended Use
- Limited to the first level identification range of the "Cholesterol (Total) Test System (A.1175)" of the Measures for the Classification and Grading Management of Medical Equipment.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1175 Cholesterol (Total) Testing System
- Import Information
- 國產;; QMS/QSD
Dates and status
- Registration Date
- Aug 24, 2022
- Expiry Date
- Aug 24, 2027
About this record
Access comprehensive regulatory information for 2nd Generation Total Cholesterol Test System (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 9428a4d34bb5b071649156d13349fc60 and manufactured by Qinli Biotechnology Co., Ltd. New North Plant. The authorized representative in Taiwan is GENERAL LIFE BIOTECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices